Maintenance of normoglycemia during cardiac surgery

Anesthesia and Analgesia

Volumn 99, Issue 2, 2004, Pages 319-324

  Carvalho, George ^a   Moore, Anne ^a   Qizilbash, Baqir ^a   Lachapelle, Kevin ^a   Schricker, Thomas ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIC NORMOGLYCEMIC CLAMP TECHNIQUE; INSULIN INFUSION; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 3242765962     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000121769.62638.EB     Document Type: Article

References (25)

1. Schricker T, Latterman R, Schreiber M, et al. The hyperglycemic response to surgery: pathophysiology, clinical implications and modification by the anaesthetic technique. Clin Intensive Care 1998;9:118-28.
2. Lee KU, Lee HK, Koh CS, Min HK. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 1988;31:285-90.
3. Lehot JJ, Piriz H, Villard J, et al. Glucose homeostasis: comparison between hypothermic and normothermic cardiopulmonary bypass. Chest 1992;102:106-11.
4. Kuntschen FR, Galletti PM, Hahn C. Glucose-insulin interactions during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986;91:451-9.
5. Tsubo T, Kudo T, Matsuki A, Oyama T. Decreased glucose utilization during prolonged anaesthesia and surgery. Can J Anaesth 1990;37:645-9.
6. Galletti PM, Kuntschen FR, Hahn C. Experimental and clinical studies with servo-controlled glucose and insulin administration during cardiopulmonary bypass. Mt Sinai J Med 1985;52:500-7.
7. Braden H, Cheema-Dhadli S, Mazer D, et al. Hyperglycemia during normothermic cardiopulmonary bypass: the role of the kidney. Ann Thorac Surg 1998;65:1588-93.
8. Kuntschen FR, Galletti PM, Hahn C, et al. Alterations of insulin and glucose metabolism during cardiopulmonary bypass under normothermia. J Thorac Cardiovasc Surg 1985;89:97-106.
9. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
10. Van den Berghe G, Bouillon R, Lauwers P. Supplement to: intensive insulin therapy in critically ill patients. N Engl J Med 2002;346:1586-8.
11. Lanier WL. Glucose management during cardiopulmonary bypass: cardiovascular and neurological implications. Anesth Analg 1991;72:423-7.
12. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetics patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-62.
13. Mangano CM, Diamondstone LS, Ramsey JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization - The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
14. Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 1998;26:225-35.
15. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 1999;89:1091-5.
16. Rassias AJ, Givan AL, Marrin CAS, et al. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002;94:1113-9.
17. Groban L, Butterworth J, Legault C, et al. Intraoperative insulin therapy does not reduce the need for inotropic or antiarrhythmic therapy after cardiopulmonary bypass. J Cardiothorac Anaesth 2002;16:405-12.
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
19. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981;240:E630-9.
20. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin dependent diabetes mellitus. Metabolism 1988;37:15-21.
21. Campbell PJ, Carlson MG. Impact of obesity on insulin action in NIDDM. Diabetes 1993;42:405-10.
22. Bovill JG, Sebel PS, Fiolet JW, et al. The influence of sufentanil on endocrine and metabolic responses to cardiac surgery. Anesth Analg 1983;62:391-7.
23. Nolan JJ, Ludvik B, Baloga J, et al. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM. Diabetes 1997;46:994-1000.
24. Bruemmer-Smith S, Avidan MS, Harris B, et al. Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesth 2002;88:489-95.
25. Lazar HL, Chipkin S, Philippides G, et al. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000;70:145-50.